BOULDER, Colo., March 5, 2018 /PRNewswire/ -- Array BioPharma Inc. ARRY today announced that its Chief Executive Officer, Ron Squarer, will speak at the Cowen 38th Annual Healthcare Conference in Boston. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: |
Cowen 38th Annual Healthcare Conference |
Presenter: |
Ron Squarer, Chief Executive Officer, Array BioPharma |
Date: |
Monday, March 12, 2018 |
Time: |
11:20 a.m. Eastern Time |
Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). For more information on Array, please go to www.arraybiopharma.com.
CONTACT:
Andrea N. Flynn, Ph.D.
Senior Director, Investor Relations & Corporate Communications
(303) 381-6600
ir@arraybiopharma.com
View original content with multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-cowen-38th-annual-healthcare-conference-300608207.html
SOURCE Array BioPharma Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.